DEVELOPMENT OF A UPLC ASSAY METHOD OF DANAZOL USING QbD APPROACH
article
OA: closed
CC0
⤵ 1 in-corpus citation
AI-generated summary
A stability-indicating ultra performance liquid chromatographic method for Danazol estimation was developed using a Quality by Design approach, demonstrating excellent resolution of degradation products.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
A novel stability-indicating reverse phase ultra performance liquid chromatographic method was developed for the estimation of Danazol. To establish specificity and to develop a stability indicating method, Danazol was subjected to the stress conditions like oxidative, acid, base, hydrolytic, thermal and photolytic degradation. Chromatographic separation was achieved on ultra performance liquid chromatography (UPLC) by quality by design (QbD) approach. The eluted compounds were monitored at 270 nm. All the degradation products were well resolved from the main peak, proving the stability-indicating power of the method. The developed method was validated as per International Conference on Harmonization (ICH) guidelines with respect to specificity, precision, linearity, accuracy, robustness and ruggedness.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
- Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer. 2003
- Comparison of tamoxifen with danazol in the management of fibrocystic disease 2010
Cited by (1)
- Danazol 2022
References (12)
- Comparison of tamoxifen with danazol in the management of fibrocystic disease via openalex
- Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer. via openalex
- W2182673157 via openalex
- W2185366565 via openalex
- W2470431263 via openalex
- W2476395098 via openalex
- doi:10.1007/s00228-009-0771-z via openalex
- doi:10.3797/scipharm.1310-17 via openalex
- doi:10.1093/chrsci/49.6.439 via openalex
- W1588515918 via openalex
- doi:10.66617/001c.1122 via openalex
- W2170736350 via openalex
Cited by (1)
- Danazol 2022
Source provenance
- openalex
- last seen: 2026-05-10T10:07:21.701259+00:00
License: CC0
· commercial use OK